vs
Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and SoFi Technologies, Inc. (SOFI). Click either name above to swap in a different company.
SoFi Technologies, Inc. is the larger business by last-quarter revenue ($1.1B vs $722.5M, roughly 1.5× Amneal Pharmaceuticals, Inc.). SoFi Technologies, Inc. runs the higher net margin — 15.2% vs 10.8%, a 4.4% gap on every dollar of revenue. On growth, SoFi Technologies, Inc. posted the faster year-over-year revenue change (42.6% vs 3.9%). Over the past eight quarters, SoFi Technologies, Inc.'s revenue compounded faster (35.6% CAGR vs 1.5%).
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
SoFi Technologies, Inc. is an American financial technology company. Founded in 2011 by Stanford University students, it operates as a nationally chartered online bank and is a technology provider to other financial institutions. SoFi is the largest U.S. based online lender, and has 13.7 million customers as of 2025.
AMRX vs SOFI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $722.5M | $1.1B |
| Net Profit | $78.0M | $166.7M |
| Gross Margin | 44.3% | — |
| Operating Margin | 19.6% | — |
| Net Margin | 10.8% | 15.2% |
| Revenue YoY | 3.9% | 42.6% |
| Net Profit YoY | 410.5% | 897.2% |
| EPS (diluted) | $0.19 | $0.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $722.5M | $1.1B | ||
| Q4 25 | $814.3M | $1.0B | ||
| Q3 25 | $784.5M | $961.6M | ||
| Q2 25 | $724.5M | $854.9M | ||
| Q1 25 | $695.4M | $771.8M | ||
| Q4 24 | $730.5M | $734.1M | ||
| Q3 24 | $702.5M | $697.1M | ||
| Q2 24 | $701.8M | $598.6M |
| Q1 26 | $78.0M | $166.7M | ||
| Q4 25 | $35.1M | $173.5M | ||
| Q3 25 | $2.4M | $139.4M | ||
| Q2 25 | $22.4M | $97.3M | ||
| Q1 25 | $12.2M | $71.1M | ||
| Q4 24 | $-31.1M | $332.5M | ||
| Q3 24 | $-156.0K | $60.7M | ||
| Q2 24 | $6.0M | $17.4M |
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | 84.2% | ||
| Q3 25 | 34.9% | 83.2% | ||
| Q2 25 | 39.5% | 82.4% | ||
| Q1 25 | 36.8% | 82.4% | ||
| Q4 24 | 36.0% | 82.5% | ||
| Q3 24 | 38.4% | 82.3% | ||
| Q2 24 | 35.6% | 81.7% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 13.8% | 18.1% | ||
| Q3 25 | 9.0% | 15.4% | ||
| Q2 25 | 15.4% | 13.1% | ||
| Q1 25 | 14.4% | 10.3% | ||
| Q4 24 | 10.4% | 8.2% | ||
| Q3 24 | 12.6% | 9.2% | ||
| Q2 24 | 13.6% | 2.6% |
| Q1 26 | 10.8% | 15.2% | ||
| Q4 25 | 4.3% | 16.9% | ||
| Q3 25 | 0.3% | 14.5% | ||
| Q2 25 | 3.1% | 11.4% | ||
| Q1 25 | 1.8% | 9.2% | ||
| Q4 24 | -4.3% | 45.3% | ||
| Q3 24 | -0.0% | 8.7% | ||
| Q2 24 | 0.9% | 2.9% |
| Q1 26 | $0.19 | $0.12 | ||
| Q4 25 | $0.10 | $0.14 | ||
| Q3 25 | $0.01 | $0.11 | ||
| Q2 25 | $0.07 | $0.08 | ||
| Q1 25 | $0.04 | $0.06 | ||
| Q4 24 | $-0.10 | $0.31 | ||
| Q3 24 | $0.00 | $0.05 | ||
| Q2 24 | $0.02 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $197.7M | $3.4B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $10.8B |
| Total Assets | $3.5B | $53.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $197.7M | $3.4B | ||
| Q4 25 | $282.0M | $4.9B | ||
| Q3 25 | $201.2M | $3.2B | ||
| Q2 25 | $71.5M | $2.1B | ||
| Q1 25 | $59.2M | $2.1B | ||
| Q4 24 | $110.6M | $2.5B | ||
| Q3 24 | $74.0M | $2.4B | ||
| Q2 24 | $43.8M | $2.3B |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.2B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | — | $10.8B | ||
| Q4 25 | $-70.8M | $10.5B | ||
| Q3 25 | $-109.5M | $8.8B | ||
| Q2 25 | $-112.1M | $6.9B | ||
| Q1 25 | $-131.7M | $6.7B | ||
| Q4 24 | $-109.3M | $6.5B | ||
| Q3 24 | $-93.4M | $6.1B | ||
| Q2 24 | $-57.5M | $5.9B |
| Q1 26 | $3.5B | $53.7B | ||
| Q4 25 | $3.7B | $50.7B | ||
| Q3 25 | $3.6B | $45.3B | ||
| Q2 25 | $3.4B | $41.1B | ||
| Q1 25 | $3.4B | $37.7B | ||
| Q4 24 | $3.5B | $36.3B | ||
| Q3 24 | $3.5B | $34.4B | ||
| Q2 24 | $3.5B | $32.6B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRX
Segment breakdown not available.
SOFI
| Loans and securitizations | $932.2M | 85% |
| Loan origination, sales, securitizations and servicing | $142.2M | 13% |
| Corporate borrowings | $10.7M | 1% |
| Securitizations and warehouses | $10.1M | 1% |
